Clinical Infectious Diseases
@cidjournal.bsky.social
The world's leading journal on infectious diseases. Clinical ID, public health, microbiology, and everything in-between. Official publication of @idsainfo.bsky.social
The clinical thermometer as the first home test for infectious disease
✅ Just Accepted
🔗 https://bit.ly/49RZP45
✅ Just Accepted
🔗 https://bit.ly/49RZP45
February 5, 2026 at 11:37 PM
The clinical thermometer as the first home test for infectious disease
✅ Just Accepted
🔗 https://bit.ly/49RZP45
✅ Just Accepted
🔗 https://bit.ly/49RZP45
February 4, 2026 at 11:01 PM
February 3, 2026 at 10:20 PM
February 2, 2026 at 10:29 PM
Cefixime for the Treatment of Neisseria gonorrhoeae Infections in a Setting With Increased Antimicrobial Resistance: A Retrospective Study in Hanoi, Vietnam
📚 In Issue
🔗 https://bit.ly/4a6VNn5
📚 In Issue
🔗 https://bit.ly/4a6VNn5
February 1, 2026 at 11:35 PM
Cefixime for the Treatment of Neisseria gonorrhoeae Infections in a Setting With Increased Antimicrobial Resistance: A Retrospective Study in Hanoi, Vietnam
📚 In Issue
🔗 https://bit.ly/4a6VNn5
📚 In Issue
🔗 https://bit.ly/4a6VNn5
The Invisible Tide of Neisseria gonorrhoeae Treatment Failures: A Review and Commentary
📚 In Issue
🔗 https://bit.ly/4btUqS3
📚 In Issue
🔗 https://bit.ly/4btUqS3
February 1, 2026 at 5:19 AM
The Invisible Tide of Neisseria gonorrhoeae Treatment Failures: A Review and Commentary
📚 In Issue
🔗 https://bit.ly/4btUqS3
📚 In Issue
🔗 https://bit.ly/4btUqS3
Mycobacterium tuberculosis Transmission in Healthcare Settings: A Systematic Review of Frequency, Risk Factors, and Exposure Conditions
✅ Just Accepted
🔗 https://bit.ly/4qKxqmo
✅ Just Accepted
🔗 https://bit.ly/4qKxqmo
January 31, 2026 at 4:17 AM
Mycobacterium tuberculosis Transmission in Healthcare Settings: A Systematic Review of Frequency, Risk Factors, and Exposure Conditions
✅ Just Accepted
🔗 https://bit.ly/4qKxqmo
✅ Just Accepted
🔗 https://bit.ly/4qKxqmo
The Erosion of a Pillar of Public Health: ACIP’s Role and the Future of U.S. Vaccine Policy Post–June 2025
✅ Just Accepted
🔗 https://bit.ly/4qRxjpk
✅ Just Accepted
🔗 https://bit.ly/4qRxjpk
January 29, 2026 at 11:51 PM
The Erosion of a Pillar of Public Health: ACIP’s Role and the Future of U.S. Vaccine Policy Post–June 2025
✅ Just Accepted
🔗 https://bit.ly/4qRxjpk
✅ Just Accepted
🔗 https://bit.ly/4qRxjpk
Infections After Kidney Transplantation from Donors with HIV to Recipients with HIV: Insights, Prevention, and the Path Forward
✅ Just Accepted
🔗 https://bit.ly/49FrvI9
✅ Just Accepted
🔗 https://bit.ly/49FrvI9
January 27, 2026 at 12:37 AM
Infections After Kidney Transplantation from Donors with HIV to Recipients with HIV: Insights, Prevention, and the Path Forward
✅ Just Accepted
🔗 https://bit.ly/49FrvI9
✅ Just Accepted
🔗 https://bit.ly/49FrvI9
The Tantalizing Pursuit for a Perfect Diagnostic Test: Balancing Innovation With Stewardship
✅ Just Accepted
🔗 https://bit.ly/3ZzrLnc
✅ Just Accepted
🔗 https://bit.ly/3ZzrLnc
January 26, 2026 at 10:48 PM
The Tantalizing Pursuit for a Perfect Diagnostic Test: Balancing Innovation With Stewardship
✅ Just Accepted
🔗 https://bit.ly/3ZzrLnc
✅ Just Accepted
🔗 https://bit.ly/3ZzrLnc
Future Prospects for Using Clinical Phenotypes in Tuberculosis Precision Medicine—An Approach for Clinical Management
✅ Just Accepted
🔗 https://bit.ly/49En9SK
✅ Just Accepted
🔗 https://bit.ly/49En9SK
January 26, 2026 at 3:29 AM
Future Prospects for Using Clinical Phenotypes in Tuberculosis Precision Medicine—An Approach for Clinical Management
✅ Just Accepted
🔗 https://bit.ly/49En9SK
✅ Just Accepted
🔗 https://bit.ly/49En9SK
Short-Course Tuberculosis Preventive Therapy in a High Migration Setting: Early Experience With 1HP in Cook County, Illinois
✅ Just Accepted
🔗 https://bit.ly/4r7HlCk
✅ Just Accepted
🔗 https://bit.ly/4r7HlCk
January 25, 2026 at 11:12 PM
Short-Course Tuberculosis Preventive Therapy in a High Migration Setting: Early Experience With 1HP in Cook County, Illinois
✅ Just Accepted
🔗 https://bit.ly/4r7HlCk
✅ Just Accepted
🔗 https://bit.ly/4r7HlCk
Pregnant women with MDR/RR-TB and the all-oral 6-month regimen: experiences from a patient series in South Africa
✅ Just Accepted
🔗 https://bit.ly/3LvoTog
✅ Just Accepted
🔗 https://bit.ly/3LvoTog
January 24, 2026 at 9:55 PM
Pregnant women with MDR/RR-TB and the all-oral 6-month regimen: experiences from a patient series in South Africa
✅ Just Accepted
🔗 https://bit.ly/3LvoTog
✅ Just Accepted
🔗 https://bit.ly/3LvoTog
Symptomatic and asymptomatic norovirus infections in early life; The PREVAIL Cohort, 2017-2020
✅ Just Accepted
🔗 https://bit.ly/4qVAIUd
✅ Just Accepted
🔗 https://bit.ly/4qVAIUd
January 23, 2026 at 4:58 PM
Symptomatic and asymptomatic norovirus infections in early life; The PREVAIL Cohort, 2017-2020
✅ Just Accepted
🔗 https://bit.ly/4qVAIUd
✅ Just Accepted
🔗 https://bit.ly/4qVAIUd
Valley Fever in Central California: Diagnosis is Not the Finish Line, the Real Gap is Longitudinal Care
✅ Just Accepted
🔗 https://bit.ly/4pWxxdk
✅ Just Accepted
🔗 https://bit.ly/4pWxxdk
January 23, 2026 at 4:07 PM
Valley Fever in Central California: Diagnosis is Not the Finish Line, the Real Gap is Longitudinal Care
✅ Just Accepted
🔗 https://bit.ly/4pWxxdk
✅ Just Accepted
🔗 https://bit.ly/4pWxxdk
Safety and Immunogenicity of a Fourth Dose of Omicron-BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18‒55 Years Old
✅ Just Accepted
🔗 https://bit.ly/4qub4FC
✅ Just Accepted
🔗 https://bit.ly/4qub4FC
January 23, 2026 at 2:45 AM
Safety and Immunogenicity of a Fourth Dose of Omicron-BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18‒55 Years Old
✅ Just Accepted
🔗 https://bit.ly/4qub4FC
✅ Just Accepted
🔗 https://bit.ly/4qub4FC
Current Epidemiology and Infection Characteristics of Non-Aspergillus Mold Infections: A Multicenter Study in Australia and New Zealand
✅ Just Accepted
🔗 https://bit.ly/4bLllbS
✅ Just Accepted
🔗 https://bit.ly/4bLllbS
January 22, 2026 at 9:46 PM
Current Epidemiology and Infection Characteristics of Non-Aspergillus Mold Infections: A Multicenter Study in Australia and New Zealand
✅ Just Accepted
🔗 https://bit.ly/4bLllbS
✅ Just Accepted
🔗 https://bit.ly/4bLllbS
Evaluating the Cepheid Xpert TB/LTBI research-use-only assay for detection of active and latent Mycobacterium tuberculosis infection
✅ Just Accepted
🔗 https://bit.ly/3LGbvxy
✅ Just Accepted
🔗 https://bit.ly/3LGbvxy
January 21, 2026 at 11:01 PM
Evaluating the Cepheid Xpert TB/LTBI research-use-only assay for detection of active and latent Mycobacterium tuberculosis infection
✅ Just Accepted
🔗 https://bit.ly/3LGbvxy
✅ Just Accepted
🔗 https://bit.ly/3LGbvxy
Xenodiagnosis to search for Borrelia burgdorferi after antibiotic treatment of Lyme disease: a prospective cohort study
✅ Just Accepted
🔗 https://bit.ly/45nxLmB
✅ Just Accepted
🔗 https://bit.ly/45nxLmB
January 21, 2026 at 9:11 PM
Xenodiagnosis to search for Borrelia burgdorferi after antibiotic treatment of Lyme disease: a prospective cohort study
✅ Just Accepted
🔗 https://bit.ly/45nxLmB
✅ Just Accepted
🔗 https://bit.ly/45nxLmB
January 21, 2026 at 12:38 AM
Diagnostic Yield of Repeat Blood Cultures and Risk Factors for Bloodstream Infection in Persistent Febrile Neutropenia
✅ Just Accepted
🔗 https://bit.ly/49vOg2l
✅ Just Accepted
🔗 https://bit.ly/49vOg2l
January 21, 2026 at 12:32 AM
Diagnostic Yield of Repeat Blood Cultures and Risk Factors for Bloodstream Infection in Persistent Febrile Neutropenia
✅ Just Accepted
🔗 https://bit.ly/49vOg2l
✅ Just Accepted
🔗 https://bit.ly/49vOg2l
Personalized Antibiogram: A Novel Multi-Task Machine Learning Framework for Simultaneous Prediction of Antimicrobial Resistance Profile with Enhanced Detection of Carbapenem Resistance in Enterobacteriaceae
✅ Just Accepted
🔗 https://bit.ly/49u8eKW
✅ Just Accepted
🔗 https://bit.ly/49u8eKW
January 19, 2026 at 7:26 PM
Personalized Antibiogram: A Novel Multi-Task Machine Learning Framework for Simultaneous Prediction of Antimicrobial Resistance Profile with Enhanced Detection of Carbapenem Resistance in Enterobacteriaceae
✅ Just Accepted
🔗 https://bit.ly/49u8eKW
✅ Just Accepted
🔗 https://bit.ly/49u8eKW
Effect of Direct-from-blood Bacterial Testing on Antibiotics Administration in Adults Presenting With Acute Infection: A Randomized Trial
✅ Just Accepted
🔗 https://bit.ly/3Np1KV2
✅ Just Accepted
🔗 https://bit.ly/3Np1KV2
January 19, 2026 at 8:17 AM
Effect of Direct-from-blood Bacterial Testing on Antibiotics Administration in Adults Presenting With Acute Infection: A Randomized Trial
✅ Just Accepted
🔗 https://bit.ly/3Np1KV2
✅ Just Accepted
🔗 https://bit.ly/3Np1KV2
Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological Profiles
✅ Just Accepted
https://bit.ly/4qAWI6r
✅ Just Accepted
https://bit.ly/4qAWI6r
Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological Profiles
This prospective cohort followed 741 people with HIV switching to long-acting intramuscular cabotegravir/rilpivirine. No hepatitis B virus (HBV) incident i
bit.ly
January 18, 2026 at 6:35 PM
Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological Profiles
✅ Just Accepted
https://bit.ly/4qAWI6r
✅ Just Accepted
https://bit.ly/4qAWI6r
Predicted Preferences for Tuberculosis Point-of-Care Tests among Tuberculosis-Affected Individuals in Five High Burden Countries
✅ Just Accepted
🔗 https://bit.ly/3Lyvb6u
✅ Just Accepted
🔗 https://bit.ly/3Lyvb6u
January 18, 2026 at 7:59 AM
Predicted Preferences for Tuberculosis Point-of-Care Tests among Tuberculosis-Affected Individuals in Five High Burden Countries
✅ Just Accepted
🔗 https://bit.ly/3Lyvb6u
✅ Just Accepted
🔗 https://bit.ly/3Lyvb6u